Inhaled budesonide aerosols in treatment of childhood asthma.
No Thumbnail Available
Date
1988-12-01
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Twenty-six children with chronic bronchial asthma, 19 boys and 7 girls, aged between 6 and 16 years with duration of asthma ranging from 1-12 years, were studied by a control, oral prednisolone 5 mg twice a day and inhaled budesonide 200 micrograms twice daily, each for 3 weeks. The clinical efficacy assessed daily by day and night symptom scores of cough, wheeze, sleep disturbance, limitation of activity, symptomatic inhaled terbutaline usage, daily morning and afternoon Peak Expiratory Flow Rate (PEFR), and weekly PEFR and Forced Expiratory Volume in 1 second (FEV1) in percent of predict, showed statistically significant improvement during the inhaled budesonide aerosol and oral prednisolone treatment periods in comparison with the control. No side effect was observed during any study periods.
Description
Published by the Allergy and Immunology Society of Thailand.
Keywords
Citation
Phanichyakarn P, Wong EC. Inhaled budesonide aerosols in treatment of childhood asthma. Asian Pacific Journal of Allergy and Immunology. 1988 Dec; 6(2): 111-5